av/pliant-therapeutics--big.svg

COM:PLIANTRX

Pliant Therapeutics

  • Stock

Last Close

15.19

08/11 21:00

Market Cap

669.01M

Beta: -

Volume Today

388.74K

Avg: -

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PL...Show More

investor of